GLP1 receptor agonists are widely prescribed to help control blood sugar levels and support weight loss. While these ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Unfortunately, we also found that GLP-1 drugs come with significant side effects and increase the risk of 19 health ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications. Experts break down the findings.

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher.

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...